# A Trial of SHR-2173 in Healthy Volunteers

> **NCT07390747** · PHASE1 · RECRUITING · sponsor: **Atridia Pty Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Immunology

## Interventions

- **DRUG:** SHR-2173 Injection/SHR-2173 placebo

## Key facts

- **NCT ID:** NCT07390747
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-06
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07390747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07390747, "A Trial of SHR-2173 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07390747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*